12:00 AM
Jun 22, 2015
 |  BC Week In Review  |  Company News  |  Other News

Sequenom, Roche diagnostic news

The U.S. Court of Appeals for the Federal Circuit (CAFC) upheld a lower court judgment that U.S. Patent No. 6,258,540 covering prenatal diagnosis using nucleic acid analysis used in Sequenom’s MaterniT21...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >